Abstract

Sclerosing angiomatoid nodular transformation (SANT) of the spleen is a rare benign vascular lesion with unknown pathogenesis and no definitive pathognomonic radiological features. The majority of patients with SANT are asymptomatic, and the lesion is an incidental finding on cross-sectional imaging performed for unrelated reasons or during intra-abdominal surgery. However, in the symptomatic minority, abdominal pain is the most commonly reported symptom. SANT generally remains stable or has very slow growth, making it amenable to surveillance using serial cross-sectional imaging. Herein, we report the unusual case of SANT in a 30-year-old female with rapid growth from 6.0 × 5.6 × 4.4 cm to 8.0 × 6.6 × 7.2 cm over 21 months. Given the rapid growth, it was imperative to rule out malignancy. Thus, the patient underwent a laparoscopic total splenectomy. For SANT, splenectomy serves the dual purpose of diagnosis and definitive therapy.

Details

Title
Rapidly growing sclerosing angiomatoid nodular transformation of the spleen
Author
Sohail, Amir Humza 1 ; Eze, Anthony 2 ; Sachal Sohail 3 ; Yousaf, Bashir Hadi 4 ; Haider, Zishan 5 ; Maurer, James 1 

 Department of Surgery , NYU Langone Health Long Island, New York, USA 
 Harvard T. H. Chan School of Public Health , Harvard University, Cambridge, Massachusetts, USA 
 King Edward Medical University , Lahore, Pakistan 
 Section of Gastroenterology and Hepatology , Department of Medicine, West Virginia University , Morgantown, West Virginia, USA 
 National Guard Hospital , King Abdulaziz Medical City, Riyadh, Saudi Arabia 
Publication year
2021
Publication date
Sep 2021
Publisher
Oxford University Press
e-ISSN
20428812
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3170823948
Copyright
Published by Oxford University Press and JSCR Publishing Ltd. All rights reserved. © The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.